Medically Compromised Patient, 10th Edition by Kerr, Miller,
Rhodus, Stoopler, and Treister
,Little: Dental Management of the Medically Compromised Patient, 10th Edition Test Bank
Table of Contents
PART ONE: PATIENT EVALUATION AND RISK ASSESSMENT
Chapter 1: Patient Evaluation and Risk Assessment
PART TWO: CARDIOVASCULAR DISEASE
Chapter 2: Infective Endocarditis
Chapter 3: Hypertension
Chapter 4: Ischemic Heart Disease
Chapter 5: Cardiac Arrhythmias
Chapter 6: Heart Failure (or Congestive Heart Failure)
PART THREE: PULMONARY DISEASE
Chapter 7: Pulmonary Disease
Chapter 8: Smoking and Tobacco Use Cessation
Chapter 9: Sleep-Related Breathing Disorders
PART FOUR: GASTROINTESTIAL DISEASE
Chapter 10: Liver Disease
Chapter 11: Gastrointestinal Disease
PART FIVE: GENITOURINARY DISEASE
Chapter 12: Chronic Kidney Disease and Dialysis
Chapter 13: Sexually Transmitted Diseases
PART SIX: ENDOCRINE AND METABOLIC DISEASE
Chapter 14: Diabetes Mellitus
Chapter 15: Adrenal Insufficiency
Chapter 16: Thyroid Diseases
Chapter 17: Pregnancy and Breast Feeding
PART SEVEN: IMMUNOLOGIC DISEASE
Chapter 18: AIDS, HIV Infection, and Related Conditions
Chapter 19: Allergy
Chapter 20: Rheumatologic and Connective Tissue Disorders
Chapter 21: Organ and Bone Marrow Transplantation
PART EIGHT: HEMATOLOGIC AND ONCOLOGIC DISEASE
Chapter 22: Disorders of Red Blood Cells
Chapter 23: Disorders of White Blood Cells
Chapter 24: Acquired Bleeding and Hypercoagulable Disorders
Chapter 25: Congenital Bleeding and Hypercoagulable Disorders
Chapter 26: Cancer and Oral Care of the Patient
PART NINE: NEUROLOGIC, BEHAVIORAL, AND PSYCHIATRIC DISORDERS
Chapter 27: Neurologic Disorders
Chapter 28: Anxiety, Eating Disorders, and Behavioral Reactions to Illness
Chapter 29: Psychiatric Disorders
Chapter 30: Drug and Alcohol Abuse
, WWW.GRADESMORE.COM
Stuvia.com - The Marketplace to Buy and Sell your Study Material
Page 1 of 74
Chapter 01: Patient Evaluation and Risk Assessment
Little: Dental Management of the Medically Compromised Patient, 10th Edition
MULTIPLE CHOICE
1. Elective dental procedures should be postponed for patients with severe, uncontrolled hypertension,
defined as a blood pressure at or above ___ mm Hg.
a. 200/140
b. 180/140
c. 180/110
d. 160/110
ANSWER: C
Detailed Rationale: Severe, uncontrolled hypertension is defined as a systolic blood pressure ≥180 mm Hg
or a diastolic ≥110 mm Hg. Proceeding with elective dental care in such patients greatly increases the risk of
cardiovascular complications during or after the procedure, including hypertensive crisis, myocardial
infarction, or stroke. Dental treatment should be deferred until the blood pressure is stabilized by a
physician, and emergency dental care should only be provided with close monitoring and possibly in a
hospital setting.
2. According to the current American Heart Association (AHA) guidelines, antibiotic prophylaxis is
recommended for dental patients with which cardiac condition?
a. Mitral valve prolapse
b. Prosthetic heart valve
c. Rheumatic heart disease
WWW.NURSYLAB.COM
GRADESMORE.COM
, WWW.GRADESMORE.COM
Stuvia.com - The Marketplace to Buy and Sell your Study Material
Page 1 of 74
d. Pacemaker for arrhythmias
ANSWER: B
Detailed Rationale: In 2007, the AHA significantly narrowed the list of cardiac conditions requiring
prophylactic antibiotics before dental procedures to prevent infective endocarditis (IE). This is now reserved
for patients at highest risk for adverse outcomes, including those with prosthetic heart valves, previous
history of IE, certain unrepaired or incompletely repaired congenital heart defects, and heart transplant
recipients with valvulopathy. Mitral valve prolapse and rheumatic heart disease were once included but were
removed due to lack of evidence supporting the benefit of prophylaxis. Pacemakers do not increase the risk
of IE from dental bacteremia.
3. Chronic hepatitis (B or C) or liver cirrhosis can lead to a reduced ability to ___ certain medications,
including local anesthetics and pain relievers.
a. Absorb
b. Distribute
c. Metabolize
d. Excrete
ANSWER: C
Detailed Rationale: The liver is the primary site for drug metabolism. In chronic hepatitis or cirrhosis,
hepatic cells are damaged, impairing enzymatic activity needed for drug breakdown. This results in
prolonged drug half-life and potential accumulation, increasing the risk for toxicity. Local anesthetics (e.g.,
lidocaine) and analgesics (e.g., acetaminophen, NSAIDs) must be used cautiously, often at reduced doses.
Additionally, impaired protein synthesis in liver disease can lead to prolonged bleeding time, requiring
careful management during dental or surgical procedures.
WWW.NURSYLAB.COM
GRADESMORE.COM